Figure 6. Tumor somatic mutational landscape of the IBPS. (A) The top 35 gene mutations in the high-risk score group. (B) The top 35 gene mutations in the low-risk score group. (C, D) Mutations in the commonly mutated genes TP53, ERBB2, EGFR, FGFR2, MET, and KRAS in the high-risk and low-risk score groups, respectively. (E) Kaplan-Meier curves of OS in all GAC patients based on TMB. (F) Difference in TMB between the high- and low-risk groups. (G) Difference in risk scores between the high and low TMB groups.